[HTML][HTML] Monoclonal antibodies as COVID-19 prophylaxis therapy in immunocompromised patient populations
The objective of this review was to examine the latest literature regarding the effectiveness
of monoclonal antibodies as COVID-19 prophylaxis therapy for immunocompromised patient …
of monoclonal antibodies as COVID-19 prophylaxis therapy for immunocompromised patient …
[HTML][HTML] Head-to-head comparison of azvudine and nirmatrelvir/ritonavir for the hospitalized patients with COVID-19: a real-world retrospective cohort study with …
AH Wei, L Zeng, L Wang, L Gui, WT Zhang… - Frontiers in …, 2023 - frontiersin.org
Background: Nirmatrelvir/ritonavir and azvudine have been approved for the early treatment
of COVID-19 in China, however, limited real-world data exists regarding their effectiveness …
of COVID-19 in China, however, limited real-world data exists regarding their effectiveness …
Engineered Therapeutic Antibody Against SARS-CoV-2
M Chulanetra - Current Clinical Microbiology Reports, 2023 - Springer
Abstract Purpose of Review The success and failure of therapeutic antibodies against SARS-
CoV-2 offer a lesson on therapeutic antibody design and development. Recent Findings …
CoV-2 offer a lesson on therapeutic antibody design and development. Recent Findings …
[HTML][HTML] COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant
J Martínez-López, J de la Cruz, R Gil-Manso, VJ Yuste… - Cancers, 2024 - mdpi.com
Simple Summary This HEMATO-MADRID COVID-19 study assessed COVID-19 outcomes in
1818 hematologic cancer patients from February 2020 to October 2022 across different …
1818 hematologic cancer patients from February 2020 to October 2022 across different …
Omicron variants of SARS CoV-2 indicate how small molecules can interfere with spike glycoprotein trimerization
N Niccolai, A Trezza, F Marchini… - Applied …, 2023 - systems.enpress-publisher.com
In our search for a possible achilles' heel of SARS-CoV-2, we explored the variability of
1,382,462 complete sequences of the viral spike glycoprotein, all the ones that we could …
1,382,462 complete sequences of the viral spike glycoprotein, all the ones that we could …
[PDF][PDF] Upgrade on Monoclonal Antibodies as Prophylaxis-Therapy in the Elderly and Immunocompromised Sars-Cov-2 Population
LE Weimer, G Cattari, E Fanales Belasio… - A Review. SunText …, 2023 - suntextreviews.org
COVID-19 is highly transmissible with potentially serious health outcomes, underscoring the
need for effective prevention and treatment strategies. Vaccines are highly effective at …
need for effective prevention and treatment strategies. Vaccines are highly effective at …